OTC manufacturer takes BestCo as its new moniker
MOORESVILLE, N.C. — BestCo is the new name for BestSweet, a manufacturer, developer and marketer of consumer healthcare products.
The former moniker BestSweet was so named due to the company’s origins as a candy manufacturer. BestCo has since evolved to become one of the largest suppliers of cough drops, throat drops, soft chews, coated chews and other confectionery-based dosage forms for OTC drug products and dietary supplements, the company stated.
“While we had long been considered a leader in a range of confectionery categories, our business has transitioned in the past 10 years with the development of dosage forms for active ingredients that we have made more palatable," stated Richard Zulman, BestCo CEO. "We have transitioned into a consumer healthcare and supplement company. So it was time to move on from the BestSweet name."
The name change announcement coincides with the launch of a new BestCo corporate logo, website Bestco.com and an integrated launch campaign.
BestCo started in 1976 in Newark, N.J. 2013 marks its 25th anniversary in Mooresville, N.C., where it operates its corporate headquarters and manufacturing facilities on a 40-acre campus.
“We believe the new BestCo name and logo signal to customers, employees and suppliers that our company is strong, viable and poised for continued growth in the consumer healthcare industry,” added Zulman.
Fuse Science announces rollout strategy for its energy drops — select Walgreens near PGA tourneys
MIAMI LAKES, Fla. — Fuse Science on Thursday announced extended distribution for its PowerFuse and ElectroFuse energy drops across select Walgreens stores in the Ponte Verde, Fla., market for the Players Championship Tournament. Point-of-purchase displays feature NFL’s Arian Foster and David Ortiz of MLB’s Boston Red Sox.
The Fuse Science distribution strategy is focused on rolling out product lines within Walgreens locations situated near select PGA tournaments around the country up until, and including, the 2013 U.S. Open in June.
"We are very pleased with the new distribution relationship we have established with Walgreens," stated Brian Tuffin, CEO of Fuse Science. "We’ve been working extremely hard in establishing the right alliances with strong financial terms to ensure the success of the consumer business. We have been very deliberate in our strategy, and continue to make measured progress against our primary objective to build a major national distribution presence for the ‘Powered By Fuse’ brands," he said. "This distribution agreement, and others we expect to announce in the future, reflects a milestone for the retail distribution of our products that we believe will set the stage for the ramp-up of revenue generation and substantial growth of Fuse Science."
FDA approves Breo Ellipta for COPD
SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.
The FDA announced the approval of Breo Ellipta (fluticasone furoate and vilanterol), a once-per-day inhaler made by GlaxoSmithKline and Theravance for long-term treatment of COPD, which includes chronic bronchitis and emphysema.
"COPD is a serious disease that makes breathing difficult," FDA Office of Drug Evaluation II director Curtis Rosebraugh said. "The availability of new, long-term maintenance medications provides additional treatment options for the millions of Americans who suffer with COPD."